Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07092761

Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
Henan University of Science and Technology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is to evaluate the accuracy and safety of a novel real-time CGM system among adult patients with type 1 diabetes mellitus with respect to YSI reference venous plasma sample measurements.

Detailed description

The study is to evaluate the accuracy and safety of a novel real-time CGM system among adult patients with type 1 diabetes mellitus with respect to YSI reference venous plasma sample measurements. Up to 42 patients will be enrolled. Each patient will wear two sensors. Interstitial glucose readings from each sensor will be obtained immediatedly following each venous blood sample test. Each participant will make 4 visits to the clinical study site, including the screening visit.

Conditions

Interventions

TypeNameDescription
DEVICEGS3 CGMWearing CGM for a consecutive 14 days

Timeline

Start date
2025-04-01
Primary completion
2026-06-01
Completion
2026-09-01
First posted
2025-07-30
Last updated
2025-11-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07092761. Inclusion in this directory is not an endorsement.

Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System (NCT07092761) · Clinical Trials Directory